Description
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Cas No. | 104180-18-9 |
|---|---|
| Purity | ≥95% |
| Formula | C27H43N3O5S |
| Formula Wt. | 565.74 |
| Synonym | Chemotactic peptide, N-Formyl-Met-Leu-Phe-Lys |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.
Bisaniline pyrimidine; pan-kinase inhibitor.
Diterpene found in Taxus; potential microtubule...
NSAID; CB1 agonist, COX-2 inhibitor.
Peptide, derivative of AT II, involved in vasoc...
Water-soluble parthenolide analog; NF-κB inhib...
GABA derivative; GABA-B agonist.
GSK-3 inhibitor.
CB2 receptor antagonist.
ITC, sulforaphane analog.
Synthetic prednisolone prodrug; glucocorticoid ...
VEGFR inhibitor.
MET, VEGFR2, Ron, Axl, FLT3 inhibitor.
Diphenylmethane derivative, stimulates colonic ...
Pan inhibitor of ALK.
Sesquiterpene lactone derived from Artemesia; m...
MELK inhibitor.
5-HT1A partial agonist, SERT inhibitor.
Synthetic ITC.
Imidazoquinazoline; PDE3 inhibitor.